Psoriasis is a common inflammatory skin disease linked to several long-term health conditions, such as heart disease, arthritis and type 2 diabetes, and has a substantial impact on sufferers’ quality of life. Although the World Health Organization has highlighted the need for more personalized care for patients, progress has been limited by the lack of reliable biomarkers to guide clinical decision making.
This article was originally published on MedicalXpress.com

